Other

Thymalin

Thymalin has no approved use in the US. FDA calls Thymalin products sold online unapproved new drugs. It is a mix of peptides from the thymus gland. The evidence grade is limited-human: studies in Russia and Ukraine report gains, but most are small or old.

no-approved-usechecked Evidence grade limited-human · our assessmentVerified

This page has not been individually reviewed by a clinician.

Fact sheet · 5 facts

every row cites its source and its date
FactValueTierCheckedSource
Also calledTimalinpeer-reviewedpubmed.ncbi.nlm.nih.gov
Classotherpeer-reviewedpubmed.ncbi.nlm.nih.gov
Regulatory statusno-approved-useprimaryfda.gov
Status source read2026-10-26primaryfda.gov
Evidence gradelimited-humanour assessmentpeptideindex.ai

Short answer

Thymalin has no approved use in the US. FDA calls Thymalin products sold online unapproved new drugs. It is a mix of peptides from the thymus gland. The evidence grade is limited-human: studies in Russia and Ukraine report gains, but most are small or old.

Our assessment, drawn from the sources below.

What it is

Thymalin is not one peptide. It is a mix of peptides taken from the thymus [12]. The thymus is a gland in the chest that helps train the immune system. Researchers say two very short peptides in the mix may be its active parts [13].

It was first taken from animal tissue by a research group in Russia [14]. Doctors in Russia use it to support the immune system [16]. It is also spelled Timalin [15]. Thymulin and thymosin alpha-1 are different molecules, not Thymalin.

No drug approved in the US contains it [1].

What the evidence shows

Evidence grade: limited-human · our assessment

The evidence grade is limited-human: studies in people report gains, but most are small, old or poorly described, and the ones that name a place were run in Russia and Ukraine [5] [6] [7] [8].

People: in a 2003 study, 266 older people were followed. Some got Thymalin, a pineal extract called Epithalamin, or both, for the first 2 to 3 years [5]. Over 6 to 8 years, fewer people died in the treated groups than in the control group, the authors report [5]. The study came from the group that developed Thymalin, and its summary does not say how people were put in groups [5] [14]. In a 2021 report, patients with COVID-19 got Thymalin on top of usual care [6]. Blood signs of swelling and clotting fell faster [6]. In 60 patients with lung tuberculosis, adding Thymalin to drugs shortened hospital stays, a 1990 report says [7]. In 15 people with parkinsonism, a movement disorder, symptoms got better after a course of Thymalin [8]. That study compared people only with themselves, before and after [8].

Animals: in rats with a transplanted tumor, Thymalin stopped or shrank the tumor in more than half [9]. In rats with a hole in the jaw bone, Thymalin shots given with a bone graft helped the bone heal [10]. In old mice, it changed the mix of cells in bone marrow [11].

Cells: in human stem cells in a lab, Thymalin pushed cells toward mature immune cells [12]. In other lab tests, it lowered signals of swelling made by human blood cells [13] [14]. These are animal and lab results, not results in people.

Known risks

  • FDA has not tested Thymalin products sold online for harm, benefit or quality [1].
  • FDA warned that a seller marketed Thymalin for children. Children may react more strongly to untested drugs [1].

What nobody knows yet

  • Nobody knows if Thymalin helps older people live longer. The long study of older people came from the group that developed it [5] [14].
  • Nobody knows which parts of the extract do anything. A lab study points to two tiny peptides, but it used cells and computer models [13].
  • Some of the studies in people are written in Russian, with only a short English note. That makes them hard for others to check [7] [8].
  • The results in rats, mice and lab-grown cells may not hold in people [9] [11] [12].

Legitimate ways to get it

No approved drug in the US contains Thymalin, and FDA calls the products sold online unapproved new drugs [1]. The federal list of substances pharmacies may use does not name it [2] [3]. There is no legal route to Thymalin in the US today.

Any open trial would appear in the trials block below, with the date the official registry was last checked.

  • None

    There is no legal route to Thymalin in the US today. It is in no approved drug, and FDA calls Thymalin products sold online unapproved new drugs.

    fda.gov

Recruiting trials

A listing is not a recommendation. Trials have strict eligibility rules. Talk to your doctor and read the official record.

No open trials in the snapshot of .clinicaltrials.gov

How people are getting it anyway

This section describes what happens and is not a recommendation.

One way of getting Thymalin shows up in federal records: websites that sell it as a research chemical [1]. In 2024, FDA sent a warning letter to an online seller that offered Thymalin along with two weight-loss drugs [1].

The seller's labels said the products were for research only and not for people [1]. FDA said the website showed they were meant for people, so they are drugs [1]. FDA said the Thymalin product had no approval and was misbranded [1]. FDA was especially concerned that the seller marketed it for children [1].

A law firm reports that FDA has stepped up action against peptides labeled for research use only [4].

  • Research use seller

    Sold online as a research chemical, with a label saying it is not for people, while the website describes uses in people.

    The lawFDA says Thymalin products sold this way are drugs, because the website shows they are meant for people. They are unapproved new drugs and misbranded.fda.gov

    Documented riskFDA has not tested the product for harm, benefit or quality.fda.gov

    Documented riskFDA warned that the seller marketed Thymalin for children, who may react more strongly to untested drugs.fda.gov

    Enforcement FDA warning letter to an online seller of research chemicals; the letter names Thymalin as an unapproved new drug.fda.gov

Sources

  1. [1]FDA warning letter to an online seller, naming Thymalin as an unapproved new drug, 7 February 2024Regulatory · primary
  2. [2]FDA: bulk drug substances nominated under section 503A, list updated 14 May 2026Regulatory · primary
  3. [3]FDA: bulk drug substances used in compounding under section 503ARegulatory · primary
  4. [4]Health Law Alliance: FDA action on peptides sold as research use onlyLegal analysis · legal-analysis
  5. [5]Thymalin and Epithalamin in 266 older people over 6 to 8 years, 2003Human trial · peer-reviewed
  6. [6]Thymalin added to treatment of patients with COVID-19, 2021Human trial · peer-reviewed
  7. [7]Thymalin with drug treatment in 60 patients with lung tuberculosis, 1990Human trial · peer-reviewed
  8. [8]Thymalin in 15 patients with parkinsonism, 1999Human trial · peer-reviewed
  9. [9]Thymalin and a transplanted sarcoma in rats, 2018Animal · peer-reviewed
  10. [10]Thymalin shots and jaw bone repair in rats, 2024Animal · peer-reviewed
  11. [11]Thymalin and bone marrow cells in mice of different ages, 2011Animal · peer-reviewed
  12. [12]Thymalin and human blood stem cells in a lab, 2020In vitro · peer-reviewed
  13. [13]Two short peptides in Thymalin, in cells and computer models, 2023In vitro · peer-reviewed
  14. [14]Thymalin and four other peptides in a human monocyte cell line, 2022In vitro · peer-reviewed
  15. [15]Review of clinical studies of peptide bioregulators, including Timalin, 2013Reference · peer-reviewed
  16. [16]Review of immune therapies used in Russian medicine, naming thymalin, 1999Reference · peer-reviewed

Last verified · 5 facts · 7 sources

Primary source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/us-chem-labs-669074-02072024

Machine readers: JSON · Markdown · Status history: Change log

Information, not medical advice.

Status alerts

Get status alerts for Thymalin

No alert has been sent yet. Until alerts begin, the confirmation is the only email you will get.

Sent by Migration Group, LLC. No account and no marketing. Unsubscribe at any time.